Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experienceE.S. Lutrino, Saverio Cinieri, Guido Giordano et al.|Tumori Journal|2019Cited by 6
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients: Results on safety and efficacy—An Italian multicenter experience.Stefania Eufemia Lutrino, Saverio Cinieri, Laura Orlando et al.|Journal of Clinical Oncology|2016Cited by 3
Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experienceE.S. Lutrino, Saverio Cinieri, Laura Orlando et al.|Annals of Oncology|2016Cited by 1
Safety of Eribulin plus Trastuzumab in pre-treated HER2-positive advanced breast cancer (ABC) patients: results from an Italian observational studyLaura Orlando, Saverio Cinieri, E. Mazzoni et al.|Annals of Oncology|2016Cited by 0